Arecor Therapeutics plc (AIM:AREC)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
80.00
-2.50 (-3.03%)
Nov 4, 2026, 1:27 PM GMT

Arecor Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3630285673111
Market Cap Growth
34.24%9.52%-50.35%-23.94%-34.00%-
Enterprise Value
332925486089
Last Close Price
0.780.810.731.822.404.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
158.9845.77----
PS Ratio
40.7217.7316.8912.2230.5896.15
PB Ratio
9.844.715.195.874.216.00
P/TBV Ratio
9.874.725.228.975.236.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
37.2416.7315.5110.4624.9477.27

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.040.040.020.01
Net Debt / Equity Ratio
-0.84-0.93-0.57-0.67-0.72-0.97
Net Debt / EBITDA Ratio
0.621.540.610.721.233.07
Net Debt / FCF Ratio
0.672.450.321.071.133.28
Asset Turnover
0.180.200.140.250.110.09
Inventory Turnover
--1.163.49--
Quick Ratio
4.294.222.081.964.198.77
Current Ratio
4.694.782.532.174.699.05
Return on Equity (ROE)
-1.44%15.79%-69.41%-63.41%-51.44%-63.85%
Return on Assets (ROA)
-64.57%-30.05%-26.85%-30.88%-30.28%-29.64%
Return on Invested Capital (ROIC)
-872.70%-276.24%-190.40%-227.95%-209.46%-
Return on Capital Employed (ROCE)
-137.20%-62.30%-94.70%-89.70%-57.30%-32.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.63%2.19%-36.88%-15.30%-12.60%-5.54%
FCF Yield
-12.72%-8.10%-33.65%-10.72%-15.08%-4.96%
Buyback Yield / Dilution
-11.97%-17.94%-9.20%-5.83%-25.63%-41.77%